Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
International Journal of Medicinal Mushrooms

Импакт фактор: 1.357

ISSN Печать: 1521-9437
ISSN Онлайн: 1940-4344

Выпуски:
Том 19, 2017 Том 18, 2016 Том 17, 2015 Том 16, 2014 Том 15, 2013 Том 14, 2012 Том 13, 2011 Том 12, 2010 Том 11, 2009 Том 10, 2008 Том 9, 2007 Том 8, 2006 Том 7, 2005 Том 6, 2004 Том 5, 2003 Том 4, 2002 Том 3, 2001 Том 2, 2000 Том 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v7.i3.890
456 pages

Dissemination of Case Studies on Ganotherapy

H. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh
S. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh
A. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh
K. Rahman
Practical Action of Intermediate Technology Development Group, House No-32, Road No-13/A, Dhanmondi, Dhaka-1209; Ganex Bangladesh (Pvt.) Ltd., Wali Center (3rd & 4th Floor), 74 Gulshan Avenue, Gulshan-1, Dhaka-1212, Bangladesh

Краткое описание

The treatment of various ailments through Ganotherapy has been initiated very recently in India and is now under experiment. However, the experiment has found some advances in the treatment of various ailments, which has been revealed through observations of different patients' ages ranging from 5 to 65 years. The time span of the ailments from which the patients suffered was 1.5 to 13 years. The purpose of the observation was to evaluate the effectiveness of the prescribed Ganoderma spp. capsules. The efforts were intended for promoting alternative medication for curing and maintaining health and at the same time creating social acceptance, adaptation, and affordability of this treatment among a greater segment of people.
During the study period, there were 20 different patients closely monitored after ingesting 500 mg capsules in various doses. All the cases were documented in a systematic way. The patients were suffering from low blood pressure (1), asthma (4), liver and stomach problem (1), obesity and health maintaining (1), prostate cancer (1), diabetes (1), paralysis (1), uterus tumor (1), gangrene (1), blood dysentery (1), respiratory and weakness problem (1), gastritis and gout (1), sinusitis and teeth problem (1), piles (1), rheumatic fever and brain disorder (1), kidney problem (1), and gynecological unwanted pains (1). According to our observations, it has been found that 80% of the patients were cured and are now leading a better quality of daily life.
It may be urged and stressed that a wider scope of clinical research work on Ganotherapy in the country is needed. International collaborative research and development activity is encouraged and welcomed on an urgent basis to continue clinical research.